The Gut Microbiome as a Major Regulator of the Gut-Skin Axis

Iman Salem, Amy Ramser, Nancy Isham, Mahmoud A Ghannoum, Iman Salem, Amy Ramser, Nancy Isham, Mahmoud A Ghannoum

Abstract

The adult intestine hosts a myriad of diverse bacterial species that reside mostly in the lower gut maintaining a symbiosis with the human habitat. In the current review, we describe the neoteric advancement in our comprehension of how the gut microbiota communicates with the skin as one of the main regulators in the gut-skin axis. We attempted to explore how this potential link affects skin differentiation and keratinization, its influence on modulating the cutaneous immune response in various diseases, and finally how to take advantage of this communication in the control of different skin conditions.

Keywords: acne vulgaris; atopic dermatitis; gut microbiome; probiotics; psoriasis; skin homeostasis.

Figures

FIGURE 1
FIGURE 1
The gut microbiome as a major regulator of the gut-skin axis.

References

    1. Abhishek S., Tech M., Krishnan S. P. (2016). Epidermal differentiation complex: a review on its epigenetic regulation and potential drug targets. Cell J. 18 1–6. 10.22074/cellj.2016.3980
    1. Agak G. W., Qin M., Nobe J., Kim M., Krutzik S. R., Tristan G. R., et al. (2014). Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J. Invest. Dermatol. 134 366–373. 10.1038/jid.2013.334
    1. Agamia N. F., Abdallah D. M., Sorour O., Mourad B., Younan D. N. (2016). Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet. Br. J. Dermatol. 174 1299–1307. 10.1111/bjd.14409
    1. Agrawal R., Wisniewski J. A., Woodfolk J. A. (2011). “The role of regulatory T cells in atopic dermatitis,” in Pathogenesis andManagement of Atopic Dermatitis Vol. 41, ed. Shiohara T. (Basel: Karger Publishers; ) 112–124.
    1. Arck P., Handjiski B., Hagen E., Pincus M., Bruenahl C., Bienenstock J., et al. (2010). Is there a ‘gut–brain–skin axis’? Exp. Dermatol. 19 401–405. 10.1111/j.1600-0625.2009.01060.x
    1. Baba H., Masuyama A., Takano T. (2006). Short communication: effects of Lactobacillus helveticus-fermented milk on the differentiation of cultured normal human epidermal keratinocytes. J. Dairy Sci. 89 2072–2075. 10.3168/jds.S0022-0302(06)72275-5
    1. Baba H., Masuyama A., Yoshimura C. (2012). Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis. U.S. Patent NO CA2614111A1.
    1. Baba H., Masuyama A., Yoshimura C., Aoyama Y., Takano T., Ohki K. (2010). Oral intake of Lactobacillus helveticus-fermented milk whey decreased transepidermal water loss and prevented the onset of sodium dodecylsulfate-induced dermatitis in mice. Biosci. Biotechnol. Biochem. 74 18–23. 10.1271/bbb.90370
    1. Bendiks M., Kopp M. V. (2013). The relationship between advances in understanding the microbiome and the maturing hygiene hypothesis. Curr. Allergy Asthma Rep. 13 487–494. 10.1007/s11882-013-0382-8
    1. Benyacoub J., Bosco N., Blanchard C., Demont A., Philippe D., Castiel-Higounenc I., et al. (2014). Immune modulation property of Lactobacillus paracasei NCC2461 (ST11) strain and impact on skin defences. Benef. Microbes 5 129–136. 10.3920/BM2013.0014
    1. Bercik P., Collins S. M. (2014). “The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis,” in Microbial Endocrinology: the Microbiota-Gut-Brain Axis in Health and Disease. Advances in Experimental Medicine and Biology Vol. 817 eds Lyte M., Cryan J. (New York, NY: springer; ).
    1. Bertelsen R. J., Brantsæter A. L., Magnus M. C., Haugen M., Myhre R., Jacobsson B., et al. (2014). Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J. Allergy Clin. Immunol. 133 165–171. 10.1016/j.jaci.2013.07.032
    1. Bhate K., Williams H. C. (2013). Epidemiology of acne vulgaris. Br. J. Dermatol. 168 474–485. 10.1111/bjd.12149
    1. Bik E. M. (2009). Composition and function of the human-associated microbiota. Nutr. Rev. 67(Suppl. 2), S164–S171. 10.1111/j.1753-4887.2009.00237.x
    1. Bin L., Leung D. Y. M. (2016). Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin. Immunol. 12:52. 10.1186/s13223-016-0158-5
    1. Bloomfield S. F., Rook G. A. W., Scott E. A., Shanahan F., Stanwell-Smith R., Turner P. (2016). Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health 136 213–224. 10.1177/1757913916650225
    1. Borovaya A., Dombrowski Y., Zwicker S., Olisova O., Ruzicka T., Wolf R., et al. (2014). Isotretinoin therapy changes the expression of antimicrobial peptides in acne vulgaris. Arch. Dermatol. Res. 306 689–700. 10.1007/s00403-014-1477-3
    1. Bowe W., Patel N. B., Logan A. C. (2014). Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benef. Microbes 5 185–199. 10.3920/BM2012.0060
    1. Bowe W. P., Logan A. C. (2011). Acne vulgaris, probiotics and the gut-brain-skin axis-back to the future? Gut Pathog. 3:1. 10.1186/1757-4749-3-1
    1. Bowe W. P., Patel N., Logan A. C. (2012). Acne vulgaris: the role of oxidative stress and the potential therapeutic value of local and systemic antioxidants. J. Drugs Dermatol. 11 742–746.
    1. Boyle R. J., Lahtinen S. J., Tang M. L. K. (2011). “Probiotics and skin,” in Nutrition and Skin, ed. Pappas A. (New York, NY: springer; ).
    1. Branchet-Gumila M. C., Boisnic S., Le Charpentier Y., Nonotte I., Montastier C., Breton L. (1999). Neurogenic modifications induced by substance P in an organ culture of human skin. Skin Pharmacol. Physiol. 12 211–220. 10.1159/000066245
    1. Bures J., Cyrany J., Kohoutova D., Förstl M., Rejchrt S., Kvetina J., et al. (2010). Small intestinal bacterial overgrowth syndrome. World J. Gastroenterol. 16 2978–2990. 10.3748/wjg.v16.i24.2978
    1. Cani P. D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 1091–1103. 10.1136/gut.2008.165886
    1. Cavinato M., Jansen-Dürr P. (2017). Molecular mechanisms of UVB-induced senescence of dermal fibroblasts and its relevance for photoaging of the human skin. Exp. Gerontol. 94 78–92. 10.1016/j.exger.2017.01.009
    1. Chang Y., Trivedi M. K., Jha A., Lin Y., Dimaano L., García-Romero M. T. (2016). Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials. JAMA Pediatr. 170 236–242. 10.1001/jamapediatrics.2015.3943
    1. Chapat L., Chemin K., Dubois B., Bourdet-Sicard R., Kaiserlian D. (2004). Lactobacillus casei reduces CD8 + T cell-mediated skin inflammation. Eur. J. Immunol. 34 2520–2528. 10.1002/eji.200425139
    1. Chen B., Li R., Yan N., Chen G., Qian W., Jiang H., et al. (2015). Astragaloside IV controls collagen reduction in photoaging skin by improving transforming growth factor-β/Smad signaling suppression and inhibiting matrix metalloproteinase-1. Mol. Med. Rep. 11 3344–3348. 10.3892/mmr.2015.3212
    1. Chen Y., Wu C., Chao Y., Lin C., Tsai H., Li Y., et al. (2017). Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice. J. Food Drug Anal. 25 559–566. 10.1016/j.jfda.2016.06.003
    1. Clarke T. B., Davis K. M., Lysenko E. S., Zhou A. Y., Yu Y., Weiser J. N. (2010). Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16 228–231. 10.1038/nm.2087
    1. Clemente J. C., Ursell L. K., Parfrey L. W., Knight R. (2012). The impact of the gut microbiota on human health: an integrative view. Cell 148 1258–1270. 10.1016/j.cell.2012.01.035
    1. Coates L., Savage L., Emery P. (2016). “Pathogenesis of psoriasis and psoriatic arthritis,” in Handbook of Psoriasis and Psoriatic Arthritis, eds Warren R., Menter A. (Cham: adis; ).
    1. Cosseau C., Devine D. A., Dullaghan E., Gardy J. L., Chikatamarla A., Gellatly S., et al. (2008). The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect. Immun. 76 4163–4175. 10.1128/IAI.00188-08
    1. Dawson A. L., Dellavalle R. P. (2013). Acne vulgaris. BMJ 346:f2634. 10.1136/bmj.f2634
    1. Dawson L. F., Donahue E. H., Cartman S. T., Barton R. H., Bundy J., McNerney R., et al. (2011). The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiol. 11:86. 10.1186/1471-2180-11-86
    1. Do J. E., Cho S., In S., Lim K., Lee S., Lee E. (2009). Psychosocial aspects of acne vulgaris: a community-based study with Korean adolescents. Ann. Dermatol. 21 125–129. 10.5021/ad.2009.21.2.125
    1. Dougan S. K., Kaser A., Blumberg R. S. (2007). “CD1 expression on antigen-presenting cells,” in T Cell Activation by CD1 and Lipid Antigens. Current Topics in Microbiology and Immunology Vol. 314 ed. Moody D. B. (Berlin: springer; ), 10.1007/978-3-540-69511-0_5
    1. Dreno B., Martin R., Moyal D., Henley J. B., Khammari A., Seite S. (2017). Skin microbiome and acne vulgaris: staphylococcus, a new actor in acne. Exp. Dermatol. 26 798–803. 10.1111/exd.13296
    1. Duman H., Topal I. O., Kocaturk E., Duman M. A. (2016). Evaluation of anxiety, depression, and quality of life in patients with acne vulgaris, and quality of life in their families. DSI 34 6–9. 10.1016/j.dsi.2015.07.002
    1. Enomoto T., Sowa M., Nishimori K., Shimazu S., Yoshida A., Yamada K., et al. (2014). Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol. Int. 63 575–585. 10.2332/allergolint.13-OA-0683
    1. Eppinga H., Konstantinov S. R., Peppelenbosch M. P., Thio H. B. (2014). The microbiome and psoriatic arthritis. Curr. Rheumatol. Rep. 16 1–8. 10.1007/s11926-013-0407-2
    1. Eppinga H., Weiland C. J. S., Thio H. B., van der Woude C. J., Nijsten T. E. C., Peppelenbosch M. P., et al. (2016). Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa. J. Crohns. Colitis 10 1067–1075. 10.1093/ecco-jcc/jjw070
    1. Esplugues E., Huber S., Gagliani N., Hauser A. E., Town T., Wan Y. Y., et al. (2011). Control of TH17 cells occurs in the small intestine. Nature 475 514–518. 10.1038/nature10228
    1. Fabbrocini G., Bertona M., Picazo Ó., Pareja-Galeano H., Monfrecola G., Emanuele E. (2016). Supplementation with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne. Benef. Microbes 7 625–630. 10.3920/BM2016.0089
    1. Farris P. K. (2016). Are skincare Products with probiotics worth the hype?. Dermatology Times, 8th, August.
    1. Fitch E., Harper E., Skorcheva I., Kurtz S. E., Blauvelt A. (2007). Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr. Rheum. Rep. 9 461–467. 10.1007/s11926-007-0075-1
    1. Forbes J. D., Van Domselaar G., Bernstein C. N. (2015). The gut microbiota in immune-mediated inflammatory diseases. Front. Microbiol. 7:1081.
    1. Fox L., Csongradi C., Aucamp M., du Plessis J., Gerber M. (2016). Treatment modalities for acne. Molecules 21:1063. 10.3390/molecules21081063
    1. Frei R., Akdis M., O’Mahony L. (2015). Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr. Opin. Gastroenterol. 31 153–158. 10.1097/MOG.0000000000000151
    1. Frei R., Lauener R. P., Crameri R., O’Mahony L. (2012). Microbiota and dietary interactions: an update to the hygiene hypothesis? Allergy 67 451–461. 10.1111/j.1398-9995.2011.02783.x
    1. Gaffen S. L., Jain R., Garg A. V., Cua D. J. (2015). IL-23-IL-17 immune axis: discovery, mechanistic understanding, and clinical testing. Nat. Rev. Immunol. 14 585–600. 10.1038/nri3707
    1. Gaur M., Dobke M., Lunyak V. V. (2014). Mesenchymal stem cells from adipose tissue in clinical applications for dermatological indications and skin aging. Int. J. Mol. Sci. 18:208. 10.3390/ijms18010208
    1. Gloster H. M., Gebauer L. E., Mistur R. L. (2016). “Cutaneous manifestations of gastrointestinal disease,” in Absolute Dermatology Review, eds Gloster H. M., Gebauer L. E., Mistur R. L. (Cham: springer; ), 10.1007/978-3-319-03218-4_48
    1. Grant M. C., Baker J. S. (2017). An overview of the effect of probiotics and exercise on mood and associated health conditions. Crit. Rev. Food Sci. Nutr. 57 3887–3893. 10.1080/10408398.2016.1189872
    1. Groeger D., O’Mahony L., Murphy E. F., Bourke J. F., Dinan T. G., Kiely B., et al. (2013). Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4 325–339. 10.4161/gmic.25487
    1. Guéniche A., Philippe D., Bastien P., Reuteler G., Blum S., Castiel-Higounenc I., et al. (2013). Randomised double-blind placebo-controlled study of the effect of Lactobacillus paracasei NCC 2461 on skin reactivity. Benef. Microbes 5 137–145. 10.3920/BM2013.0001
    1. Guéniche A. G., Benyacoub J., Buetler T. M., Smola H., Blum S. (2006). Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur. J. Dermatol. 16 511–517. 10.1684/ejd.2006.0023
    1. Guéniche A. G., Benyacoub J., Philippe D., Bastien P., Kusy N., Breton L., et al. (2010). Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur. J. Dermatol. 20 731–737. 10.1684/ejd.2010.1108
    1. Guttman-Yassky E., Lowes M. A., Fuentes-Duculan J., Zaba L. C., Cardinale I., Nograles K. E., et al. (2008). Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J. Immunol. 181 7420–7427. 10.4049/jimmunol.181.10.7420
    1. Hacini-Rachinel F., Gheit H., Le Luduec J. B., Dif F., Nancey S., Kaiserlian D. (2009). Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One 4:e4903. 10.1371/journal.pone.0004903
    1. Hay R. J., Johns N. E., Williams H. C., Bolliger I. W., Dellavalle R. P., Margolis D. J., et al. (2014). The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J. Invest. Dermatol. 134 1527–1534. 10.1038/jid.2013.446
    1. Hill C., Guarner F., Reid G., Gibson G. R., Merenstein D. J., Pot B., et al. (2014). Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 506–514. 10.1038/nrgastro.2014.66
    1. Horii Y., Kaneda H., Fujisaki Y., Fuyuki R., Nakakita Y., Shigyo T., et al. (2014). Effect of heat-killed Lactobacillus brevis SBC8803 on cutaneous arterial sympathetic nerve activity, cutaneous blood flow and transepidermal water loss in rats. J. Appl. Microbiol. 116 1274–1281. 10.1111/jam.12435
    1. Horimukai K., Morita K., Narita M., Kondo M., Kabashima S., Inoue E., et al. (2016). Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations. Allergol. Int. 65 103–108. 10.1016/j.alit.2015.09.004
    1. Huang B. L., Chandra S., Shih D. Q. (2012). Skin manifestations of inflammatory bowel disease. Front. Physiol. 3:13 10.3389/fphys.2012.00013
    1. Huang Y. J., Marsland B. J., Bunyavanich S., O’Mahoney L., Leung D. Y. M., Muraro A., et al. (2017). The microbiome in allergic disease: current understanding and future opportunities – 2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. J. Allergy Clin. Immunol. 139 1099–1110. 10.1016/j.jaci.2017.02.007
    1. Ipci K., Altıntoprak N., Muluk N. B., Senturk M., Cingi C. (2017). The possible mechanisms of the human microbiome in allergic diseases. Eur. Arch. Otorhinolaryngol. 274 1–10. 10.1007/s00405-016-4058-6
    1. Irvine A. D., Simpson E. L., Eichenfield L. F., Friedlander S. F. (2016). Review of critical issues in the pathogenesis of atopic dermatitis. Semin. Cutan Med. Surg. 35 S89–S91. 10.12788/j.sder.2016.042
    1. Jena A. K., Sahoo S. (2016). Evaluation of associated anxiety and depression in patients with acne vulgaris: a hospital based clinico-epidemiological study. PIJR 5:10 10.15373/22501991
    1. Jeong J. H., Lee C. Y., Chung D. K. (2016). Probiotic lactic acid bacteria and skin health. Crit. Rev. Food Sci. Nutr. 56 2331–2337. 10.1080/10408398.2013.834874
    1. Johnson C. C., Ownby D. R. (2017). The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases. Transl. Res. 179 60–70. 10.1016/j.trsl.2016.06.010
    1. Jung G. W., Tse J. E., Guiha I., Rao J. (2013). Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J. Cutan Med. Surg. 17 114–122. 10.2310/7750.2012.12026
    1. Katzman M., Logan A. C. (2007). Acne vulgaris: nutritional factors may be influencing psychological sequelae. Med. Hypotheses. 69 1080–1084. 10.1016/j.mehy.2007.02.037
    1. Kelleher M., Dunn-Galvin A., Hourihane J. O., Murray D., Campbell L. E., McLean W. H. I., et al. (2015). Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J. Allergy Clin. Immunol. 135 930–935. 10.1016/j.jaci.2014.12.013
    1. Kim H., Kim H. Y., Lee S., Seo J., Lee E., Hong S. (2013). Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J. Pediatr. 56 369–376. 10.3345/kjp.2013.56.9.369
    1. Kim H., Kim Y., Kang M., Seo J., Kim H., Jeong S., et al. (2012). A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus. Exp. Dermatol. 21 672–675. 10.1111/j.1600-0625.2012.01539.x
    1. Kim H. M., Lee D. E., Park S. D., Kim Y., Kim Y. J., Jeong J. W., et al. (2014). Oral administration of Lactobacillus plantarum HY7714 protects hairless mouse against ultraviolet B-induced photoaging. J. Microbiol. Biotechnol. 24 1583–1591. 10.4014/jmb.1406.06038
    1. Kim J. Y., Kwon J. H., Ahn S. H., Lee S. I., Han Y. S., Choi Y. O., et al. (2010). Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. 21 e386–93. 10.1111/j.1399-3038.2009.00958.x
    1. Kim Y. G., Udayanga K. G., Totsuka N., Weinberg J. B., Nuñez G., Shibuya A. (2014). Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe 15 95–102. 10.1016/j.chom.2013.12.010
    1. Kober M. M., Bowe W. P. (2015). The effect of probiotics on immune regulation, acne, and photoaging. Int. J. Womens Dermatol. 1 85–89. 10.1016/j.ijwd.2015.02.001
    1. Kosiewicz M. M., Dryden G. W., Chhabra A., Alard P. (2014). Relationship between gut microbiota and development of T cell associated disease. FEBS Lett. 588 4195–4206. 10.1016/j.febslet.2014.03.019
    1. Krutmann J. (2009). Pre-and probiotics for human skin. J. Dermatol. Sci. 54 1–5. 10.1016/j.jdermsci.2009.01.002
    1. Kulig P., Musiol S., Freiberger S. N., Schreiner B., Gyülveszi G., Russo G., et al. (2016). IL-12 protects from psoriasiform skin inflammation. Nat. Commun. 7:13466. 10.1038/ncomms13466
    1. Lee D. E., Huh C., Ra J., Choi I., Jeong J., Kim S., et al. (2015). Clinical evidence of effects of Lactobacillus plantarum HY7714 on skin aging: a randomized, double blind, placebo-controlled study. J. Microbiol. Biotechnol. 25 2160–2168. 10.4014/jmb.1509.09021
    1. Lee S., Yoon J., Kim Y., Jeong D., Park S., Kang D. (2016). Therapeutic effect of tyndallized Lactobacillus rhamnosus IDCC 3201 on atopic dermatitis mediated by down-regulation of immunoglobulin E in NC/Nga mice. Microbiol. Immunol. 60 468–476. 10.1111/1348-0421.12390
    1. Lee W. J., Jung H. D., Lee H. J., Kim B. S., Lee S., Kim D. W. (2008). Influence of substance-P on cultured sebocytes. Arch. Dermatol. Res. 300 311–316. 10.1007/s00403-008-0854-1
    1. Levkovich T., Poutahidis T., Smillie C., Varian B. J., Ibrahim Y. M., Lakritz J. R., et al. (2013). Probiotic bacteria induce a ‘glow of health’. PLoS One 8:e53867. 10.1371/journal.pone.0053867
    1. Lopez-Siles M., Khan T. M., Duncan S. H., Harmsen H. J. M., Garcia-Gil L. J., Flint H. J. (2012). Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl. Environ. Microbiol. 78 420–428. 10.1128/AEM.06858-11
    1. Loser K., Beissert S. (2012). Regulatory T cells: banned cells for decades. J. Invest. Dermatol. 132 864–871. 10.1038/jid.2011.375
    1. Lynn D., Umari T., Dunnick C., Dellavalle R. (2016). The epidemiology of acne vulgaris in late adolescence. Adolesc. Health Med. Ther. 7 13–25. 10.2147/AHMT.S55832
    1. Ma H., Liang S., Li J., Napierata L., Brown T., Benoit S., et al. (2008). IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118 597–607. 10.1172/JCI33263
    1. Macpherson A. J., Harris N. L. (2004). Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4 478–485. 10.1038/nri1373
    1. Mari N. L., Simão A. N. C., Dichi I. (2017). n-3 polyunsaturated fatty acids supplementation in psoriasis: a review. Nutrire 42:5 10.1186/s41110-016-0029-3
    1. Maslowski K. M., Vieira A. T., Ng A., Kranich J., Sierro F., Yu D., et al. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 1282–1286. 10.1038/nature08530
    1. McCusker M., Sidbury R. (2016). Nutrition and skin: kids are not just little people. Clin. Dermatol. 34 698–709. 10.1016/j.clindermatol.2016.07.004
    1. Meijer K., de Vos P., Priebe M. G. (2010). Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr. Opin. Clin. Nutr. Metab. Care 13 715–721. 10.1097/MCO.0b013e32833eebe5
    1. Melnik B. C. (2015). Milk. A nutrient system of mammalian evolution promoting mTORC1-dependent translation. Int. J. Mol. Sci. 16 17048–17087. 10.3390/ijms160817048
    1. Miyazaki K., Masuoka N., Kano M., Iizuka R. (2014). Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. Benef. Microbes 5 121–128. 10.3920/BM2012.0066
    1. Moore-Connors J. M., Dunn K. A., Bielawski J. P., Van Limbergen J. (2016). Novel strategies for applied metagenomics. Inflamm. Bowel Dis. 22 709–718. 10.1097/MIB.0000000000000717
    1. Muizzuddin N., Maher W., Sullivan M., Schnittger S., Mammone T. (2012). Physiological effect of a probiotic on skin. J. Cosmet. Sci. 63 385–395.
    1. Muraro A., Lemanske R. F., Hellings P. W., Akdis C. A., Bieber T., Casale T. B., et al. (2016). Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. 137 1347–1358. 10.1016/j.jaci.2016.03.010
    1. Neu J., Rushing J. (2011). Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin. Perinatol. 38 321–331. 10.1016/j.clp.2011.03.008
    1. Noureldein M. H., Eid A. A. (2018). Gut microbiota and mTOR signaling: insight on a new pathophysiological interaction. Microb. Pathog. 118 98–104. 10.1016/j.micpath.2018.03.021
    1. Ogawa M., Saiki A., Matsui Y., Tsuchimoto N., Nakakita Y., Takata Y., et al. (2016). Effects of oral intake of heat-killed Lactobacillus brevis SBC8803 (SBL88TM) on dry skin conditions: a randomized, double-blind, placebo-controlled study. Exp. Ther. Med. 12 3863–3872. 10.3892/etm.2016.3862
    1. Omenetti S., Pizarro T. T. (2015). The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome. Front. Immunol. 6:639. 10.3389/fimmu.2015.00639
    1. O’Neill C. A., Monteleone G., McLaughlin J. T., Paus R. (2016). The gut-skin axis in health and disease: a paradigm with therapeutic implications. Bioessays 38 1167–1176. 10.1002/bies.201600008
    1. Otsuka A., Nomura T., Rerknimitr P., Seidel J. A., Honda T., Kabashima K. (2017). The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunol. Rev. 278 246–262. 10.1111/imr.12545
    1. Parisi R., Symmons D. P. M., Griffiths C. E. M., Ashcroft D. M. (2013). Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J. Invest. Dermatol. 133 377–385. 10.1038/jid.2012.339
    1. Peguet-Navarro J., Dezutter-Dambuyant C., Buetler T. M., Leclaire J., Smola H., Blum S., et al. (2008). Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure – double blind, randomized, placebo controlled clinical trial. Eur. J. Dermatol. 18 504–511. 10.1684/ejd.2008.0496
    1. Petra A. I., Panagiotidou S., Hatziagelaki E., Stewart J. M., Conti P., Theoharides T. C. (2015). Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin. Ther. 37 984–995. 10.1016/j.clinthera.2015.04.002
    1. Philippe D., Blum S., Benyacoub J. (2011). Oral Lactobacillus paracasei improves skin barrier function recovery and reduces local skin inflammation. Eur. J. Dermatol. 21 279–280. 10.1684/ejd.2010.1242
    1. Picardo M., Eichenfield L. F., Tan J. (2017). Acne and Rosacea. Dermatol. Ther. (Heidelb). 7(Suppl. 1), 43–52. 10.1007/s13555-016-0168-8
    1. Pittayapruek P., Meephansan J., Prapapan O., Komine M., Ohtsuki M. (2016). Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int. J. Mol. Sci. 17:868. 10.3390/ijms17060868
    1. Poutahidis T., Kearney S. M., Levkovich T., Qi P., Varian B. J., Lakritz J. R., et al. (2013). Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One 8:e78898. 10.1371/journal.pone.0078898
    1. Prakash P., Mohite A., Gautam P. A. (2016). study of presence of depression in acne vulgaris patients. GJRA 5 107–109. 10.15373/22778160
    1. Purchiaroni F., Tortora A., Gabrielli M., Bertucci F., Gigante G., Ianiro G., et al. (2013). The role of intestinal microbiota and the immune system. Eur. Rev. Med. Pharmacol. Sci. 17 323–333.
    1. Qin Z., Balimunkwe R. M., Quan T. (2017). Age-related reduction of dermal fibroblast size up-regulates multiple matrix metalloproteinases as observed in aged human skin in vivo. Br. J. Dermatol. 177 1337–1348. 10.1111/bjd.15379
    1. Quan T., Little E., Quan H., Qin Z., Voorhees J. J., Fisher G. J. (2013). Elevated matrix metalloproteinases and collagen fragmentation in photodamaged human skin: impact of altered extracellular matrix microenvironment on dermal fibroblast function. J. Invest. Dermatol. 133 1362–1366. 10.1038/jid.2012.509
    1. Rachakonda T. D., Schupp C. W., Armstrong A. W. (2014). Psoriasis prevalence among adults in the United States. J. Am. Acad. Dermatol. 70 512–516. 10.1016/j.jaad.2013.11.013
    1. Rajilić-Stojanović M., de Vos W. M. (2014). The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev. 38 996–1047. 10.1111/1574-6976.12075
    1. Ramírez-Boscá A., Navarro-López V., Martínez-Andrés A., Such J., Francés R., de la Parte J. H., et al. (2015). Identification of bacterial DNA in the peripheral blood of patients with active psoriasis. JAMA Dermatol. 151 670–671. 10.1001/jamadermatol.2014.5585
    1. Ramrakha S., Fergusson D. M., Horwood L. J., Dalgard F., Ambler A., Kokaua J., et al. (2016). Cumulative mental health consequences of acne: 23-year follow-up in a general population birth cohort study. Br. J. Dermatol. 175 1079–1081. 10.1111/bjd.13786
    1. Rather I. A., Bajpai V. K., Kumar S., Lim J., Paek W. K., Park Y. (2016). Probiotics and atopic dermatitis: an overview. Front. Microbiol. 7:507 10.3389/fmicb.2016.00507
    1. Roberson E. D. O., Bowcock A. M. (2010). Psoriasis genetics: breaking the barrier. Trends Genet. 26 415–423. 10.1016/j.tig.2010.06.006
    1. Rodan K., Fields K., Falla T. J. (2017). Efficacy of a twice-daily, 3-step, over-the-counter skincare regimen for the treatment of acne vulgaris. Clin. Cosmet. Investig. Dermatol. 10 3–9. 10.2147/CCID.S125438
    1. Rokowska-Waluch A., Pawlaczyk M., Cybulski M., Zurawski J., Kaczmarek M., Michalak M., et al. (2016). Stressful events and serum concentration of substance P in acne patients. Ann. Dermatol. 28 464–469. 10.5021/ad.2016.28.4.464
    1. Rook G. A. W. (2012). Hygiene hypothesis and autoimmune diseases. Clin. Rev. Allergy Immunol. 42 5–15. 10.1007/s12016-011-8285-8
    1. Samuelson D. R., Welsh D. A., Shellito J. E. (2015). Regulation of lung immunity and host defense by the intestinal microbiota. Front. Microbiol. 6:1085. 10.3389/fmicb.2015.01085
    1. Sánchez B., Delgado S., Blanco-Míguez A., Lourenço A., Gueimonde M., Margolles A. (2017). Probiotics, gut microbiota, and their influence on host health and disease. Mol. Nutr. Food Res. 61:1600240. 10.1002/mnfr.201600240
    1. Sarao L. K., Arora M. (2017). Probiotics, prebiotics, and microencapsulation: a review. Crit. Rev. Food Sci. Nutr. 57 344–371. 10.1080/10408398.2014.887055
    1. Scher J. U., Ubeda C., Artacho A., Attur M., Isaac S., Reddy S. M., et al. (2015). Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 67 128–139. 10.1002/art.38892
    1. Schwarz A., Bruhs A., Schwarz T. (2017). The short-chain fatty acid sodium butyrate functions as a regulator of the skin immune system. J. Investig. Dermatol. 1 855–864. 10.1016/j.jid.2016.11.014
    1. Seite S., Bieber T. (2015). Barrier function and microbiotic dysbiosis in atopic dermatitis. Clin. Cosmet. Investig. Dermatol. 8 479–483. 10.2147/CCID.S91521
    1. Shah K. R., Boland C. R., Patel M., Thrash B., Menter A. (2013). Cutaneous manifestations of gastrointestinal disease: part I. JAAD 68 189.e1-189.e21. 10.1016/j.jaad.2012.10.037
    1. Shu M., Wang Y., Yu J., Kuo S., Coda A., Jiang Y., et al. (2013). Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One 8:e55380. 10.1371/journal.pone.0055380
    1. Simpson E. L., Chalmers J. R., Hanifin J. M., Thomas K. S., Cork M. J., McLean W. H. I., et al. (2014). Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J. Allergy Clin. Immunol. 134 818–823. 10.1016/j.jaci.2014.08.005
    1. Sirisinha S. (2016). The potential impact of gut microbiota on your health: current status and future challenges. Asian Pac. J. Allergy Immunol. 34 249–264. 10.12932/AP0803
    1. Sironi M., Clerici M. (2010). The hygiene hypothesis: an evolutionary perspective. Microbes Infect. 12 421–427. 10.1016/j.micinf.2010.02.002
    1. Siver R. (1961). Lactobacillus for the control of acne. J. Med. Soc. New Jersey 59 52–53.
    1. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Hamarán L. G., Gratadoux J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105 16731–16736. 10.1073/pnas.0804812105
    1. Song H., Yoo Y., Hwang J., Na Y., Kim H. S. (2016). Faecalibacterium prausnitzii subspecies–level dysbiosis in the human gut microbiome underlying atopic dermatitis. J. Allergy Clin. Immunol. 137 852–860. 10.1016/j.jaci.2015.08.021
    1. Stokes J. H., Pillsbury D. M. (1930). The effect on the skin of emotional and nervous states: iII. Theoretical and practical consideration of a gastro-intestinal mechanism. Arch. Derm. Syphilol. 22 962–993. 10.1001/archderm.1930.01440180008002
    1. Strachan D. P. (1989). Hay fever, hygiene, and household size. BMJ 299 1259–1260. 10.1136/bmj.299.6710.1259
    1. Takeshita J., Grewal S., Langan S. M., Mehta N. N., Ogdie A., Van Voorhees A. S., et al. (2017). Psoriasis and comorbid diseases: epidemiology. J. Am. Acad. Dermatol. 76 377–390. 10.1016/j.jaad.2016.07.064
    1. Tan J. K. L., Bhate K. (2015). A global perspective on the epidemiology of acne. Br. J. Dermatol. 172(Suppl. 1), 3–12. 10.1111/bjd.13462
    1. Theodorou V., Ait-Belgnaoui A., Agostini S., Eutamene H. (2014). Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes 5 430–436. 10.4161/gmic.29796
    1. Thomas C. M., Versalovic J. (2010). Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1 148–163. 10.4161/gmic.1.3.11712
    1. Thrash B., Patel M., Shah K. R., Boland C. R., Menter A. (2013). Cutaneous manifestations of gastrointestinal disease: part II. JAAD 68 211.e1-211.e33. 10.1016/j.jaad.2012.10.036
    1. Van Beelen A. J., Teunissen M. B., Kapsenberg M. L., de Jong E. C. (2007). Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 7 374–381. 10.1097/ACI.0b013e3282ef869e
    1. Vaughn A. R., Notay M., Clark A. K., Sivamani R. K. (2017). Skin-gut axis: the relationship between intestinal bacteria and skin health. World J. Dermatol. 6 52–58. 10.5314/wjd.v6.i4.52
    1. Verstockt B., Van Assche G., Vermeire S., Ferrante M. (2016). Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease. Exp. Opin. Biol. Ther. 17 31–47. 10.1080/14712598.2017.1258399
    1. Vijayashankar M., Raghunath N. (2012). Pustular psoriasis responding to probiotics – A new insight. Our Dermatol. 3 326–329. 10.7241/ourd.20124.71
    1. Volkova L. A., Khalif I. L., Kabanova I. N. (2001). Impact of the impaired intestinal microflora on the course of acne vulgaris. Klin. Med. (Mosk). 79 39–41.
    1. Weaver C. T., Elson C. O., Fouser L. A., Kolls J. K. (2013). The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 24 477–512. 10.1146/annurev-pathol-011110-130318
    1. Wesemann D. R., Nagler C. R. (2016). The microbiome, timing, and barrier function in the context of allergic disease. Immunity 44 728–738. 10.1016/j.immuni.2016.02.002
    1. Wiegand C., Raschke C., Elsner P. (2016). “Skin aging: a brief summary of characteristic changes,” in Textbook of Aging Skin, eds Farage M. A., Miller K. W., Maibach H. I. (Berlin: springer; ).
    1. Won T. J., Kim B., Lim Y. T., Song D. S., Park S. Y., Park E. S., et al. (2011). Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC/Nga mice. J. Appl. Microbiol. 110 1195–1202. 10.1111/j.1365-2672.2011.04981.x
    1. Wu G. D., Lewis J. D. (2013). Analysis of the human gut microbiome and association with disease. Clin. Gastroenterol. Hepatol. 11 774–777. 10.1016/j.cgh.2013.03.038
    1. Xia W., Quan T., Hammerberg C., Voorhees J. J., Fisher G. J. (2015). A mouse model of skin aging: fragmentation of dermal collagen fibrils and reduced fibroblast spreading due to expression of human matrix metalloproteinase-1. J. Dermatol. Sci. 78 79–82. 10.1016/j.jdermsci.2015.01.009
    1. Yentzer B. A., Hick J., Reese E. L., Uhas A., Feldman S. R., Balkrishnan R. (2010). Acne vulgaris in the United States: a descriptive epidemiology. Cutis 86 94–99.
    1. You G. E., Jung B. J., Kim H. R., Kim H. G., Kim T. R., Chung D. K. (2013). Lactobacillus sakei lipoteichoic acid inhibits MMP-1 induced by UVA in normal dermal fibroblasts of human. J. Microbiol. Biotechnol. 23 1357–1364. 10.4014/jmb.1306.06026
    1. Zaenglein A. L., Pathy A. L., Schlosser B. J., Alikhan A., Baldwin H. E., Berson D. S., et al. (2016). Guidelines of care for the management of acne vulgaris. J. Am. Acad. Dermatol. 74 945–973. 10.1016/j.jaad.2015.12.037
    1. Zhang H., Liao W., Chao W., Chen Q., Zeng H., Wu C., et al. (2008). Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents. J. Dermatol. 35 555–561. 10.1111/j.1346-8138.2008.00523.x
    1. Zhang L., Li Y., Li Y., Qi L., Liu X., Yuan C., et al. (2012). Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 7:e31000. 10.1371/journal.pone.0031000
    1. Zouboulis C. C. (2014). Acne as a chronic systemic disease. Clin. Dermatol. 32 389–396. 10.1016/j.clindermatol.2013.11.005

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir